Welcome to The GeoWire, Your Source for a Peek into GeoInvesting’s Research Coverage, Microcap Stock Education, Case Studies, Recommended Reading From Around the Web, Important Tweets of the Week, Premium Weekly Wrap Ups, Featured Videos, and More. Please hit the heart button if you like today’s newsletter and reply with any feedback…
As you may know by now, a weeks’ long effort of on-the-ground due diligence and research culminated in a report on agricultural company Origin Agritech Limited (NASDAQ:SEED), which currently resides on our premium portal. We have yet to decide if we are going to open the report up to the public to reveal exactly what we found. We present supporting evidence for our bullish stance on the company’s future, pictures that reveal the real story behind SEED’s efforts in producing hybrid varieties of corn in comparison to those of their competitors, real conversations with personnel at separate test facilities, one of which is government-owned, as well as with distributors who give us their honest opinions and convictions with respect to SEED’s product. A precursor to our article states:
- Building on our roots in performing on-the-ground due diligence, we visited Origin Agritech Limited (NASDAQ:SEED) facilities and discovered that the company is already growing and testing GMO crops, a fact that most investors are likely not aware of.
- Our researcher also visited a hybrid seed testing facility operated by the Chinese government to get a broader understanding of the market.
- Our interviews with agriculture distributors in China revealed that while investors are focused on SEED’s potential role in GMO, the company’s hybrid seed business is of high quality and is poised to make a comeback, confirming statements made by the company in a recent investor presentation
Given our diligence and other recent developments occurring in the country with respect to GMO initiatives, we posit a price target that can be seen here.
Hi, part of this post is for paying subscribers
Already a paying member? Log in and come back to this page.
Our premium members also…
Get Access all Model Portfolios
Receive GeoInvesting Premium Alerts
Access to all stock pitches and Research Reports
Attend live interviews and fireside chats
Interact with the GeoTeam in Monthly Forums
Get in-depth stock research on 1000’s of microcap stocks
Recommended Reading From Around The Web
Talk of booster shots is now being given a front stage as millions of people become eligible for the additional dose of the COVID-19 vaccine. Reflecting on how the pandemic gave a boost (no pun intended) to one of the stocks that we surfed, needle manufacturing company Retractable Technologies, Inc. (AMEX:RVP), it begs the question – what lies in store for companies that were able to capitalize on the medical demand for things such as needles, PPE and something as speculative as vaccine R&D? While it’s possible you’ve read up on the subject matter, a small piece by Bloomberg defines possible reasons why boosters will be in demand for the foreseeable future:
“Some of us need boosters for two reasons. The first is that the protection against mild and moderate illness provided by the initial vaccination appears to wane over time, especially among older individuals,” says Jessica Justman, an epidemiologist at Columbia University.
“The second reason is that the delta variant is more infectious. This means everyone, even vaccinated people, is more likely to get exposed to an infectious dose of the virus and have it challenge their immune system. The booster helps your immune system mount an effective response.”
While the market has likely already rooted out the players that were obviously taking advantage of investors’ appetites to preemptively invest in lighting-in-a-bottle COVID-related stocks, we still have to keep our eye out for legitimate opportunities that might present themselves should the environment evolve.
Read the Bloomberg article here.
Investors’ bullish tones have not faded as they gain interest in global and small-cap equities … overall, risk assets have taken ~76% of all ETF inflows over past month
— Liz Ann Sonders (@LizAnnSonders) November 22, 2021
— Investing.com (@Investingcom) November 22, 2021
“Your success in #investing will depend in part on your character and guts, and in part on your ability to realize at the height of ebullience and the depth of despair alike that this too shall pass.”
-John Bogle pic.twitter.com/XViHbRhIV2
— Daily Trading Quotes (@TradingQuotes_) November 22, 2021
Thanks for joining thousands of other investors who follow GeoInvesting
Your free subscription includes first access to:
- Monthly publication of “The GeoWire” Newsletter sent to you the first Tuesday of every month, covering case studies, stats and fireside chats.
- Weekly emails highlighting the past week’s coverage at GeoInvesting sent 3x a month.
Get more out of GeoInvesting by trying us our premium package for free.
Step 1 – Receive quality research investment Ideas, model portfolios and education
Step 2 – Interact with us about our favorite ideas and the research that supports it; gain insight through all tools geo offers
Step 3 – Decide to build portfolios based on our research and Model Portfolios and updates including convictions, additions and removals of holdings.